| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 200.49B | 179.35B | 196.69B | 174.34B | 162.69B | 138.41B |
| Gross Profit | 93.65B | 83.03B | 92.40B | 79.28B | 72.70B | 55.37B |
| EBITDA | 31.86B | 31.53B | 30.26B | 34.30B | 28.71B | 21.11B |
| Net Income | 19.46B | 22.10B | 18.69B | 21.70B | 17.83B | 12.28B |
Balance Sheet | ||||||
| Total Assets | 220.17B | 242.03B | 225.70B | 233.93B | 201.72B | 191.71B |
| Cash, Cash Equivalents and Short-Term Investments | 40.76B | 38.95B | 36.14B | 31.50B | 34.25B | 44.23B |
| Total Debt | 6.17B | 27.10B | 9.28B | 15.78B | 12.48B | 17.11B |
| Total Liabilities | 82.70B | 97.12B | 89.05B | 108.41B | 99.83B | 105.80B |
| Stockholders Equity | 137.47B | 144.90B | 136.65B | 125.51B | 101.89B | 85.90B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.51B | 20.14B | 12.06B | -2.68B | 21.44B |
| Operating Cash Flow | 0.00 | 16.00B | 23.10B | 15.30B | 3.35B | 22.60B |
| Investing Cash Flow | 0.00 | -13.76B | -855.00M | -18.03B | -5.73B | -648.00M |
| Financing Cash Flow | 0.00 | -1.55B | -17.12B | -798.00M | -8.73B | 5.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥19.43T | 42.68 | 12.80% | 0.78% | 10.40% | 11.67% | |
79 Outperform | ¥1.10T | 29.33 | 11.99% | 0.65% | 8.38% | 8.43% | |
76 Outperform | ¥362.88B | 16.36 | ― | 2.04% | -8.82% | 18.33% | |
72 Outperform | ¥884.79B | 60.34 | 4.03% | 2.25% | 5.36% | -24.06% | |
70 Outperform | ¥1.11T | 18.34 | 11.14% | 1.46% | 4.02% | 13.81% | |
68 Neutral | ¥468.06B | 33.98 | 5.63% | 2.35% | -3.24% | -36.64% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |